MT-RNR1 and Insulin resistance: MOTS-c not only functions as a cell-autonomous peptide but also affects a number of pathological metabolic processes in the body by acting similarly to a hormone, including insulin resistance reduction, obesity prevention, muscle function improvement, bone metabolism promotion, immune regulation enhancement, and aging postponement.